Inhibikase Therapeutics, Inc. Employee Directory
Pharmaceutical ManufacturingDelaware, United States11-50 Employees
Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of pulmonary arterial hypertension (PAH).Inhibikase is headquartered in Wilmington, DE with additional offices in Boston, Massachusetts.